Summary:
This study is being conducted with volunteers to learn more about Vistagen pharmaceuticals PH94B Nasal Spray medication. This study will be over the course of 7 weeks with 4 scheduled visits and has the option of enrolling over into the 12-month open-label extension study.
Qualified Participants Must:
• Have significant symptoms of social anxiety
•
Be between the ages of 18-65
•
Must be willing to try the Nasal investigational medication and/or placebo
Qualified Participants May Receive:
Compensation after each completed appointment for time participating in the study.